8 studies found for:    alzheimer's and long island jewish
Show Display Options
Rank Status Study
1 Completed
Has Results
Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: memantine
2 Terminated A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Bapineuzumab
3 Completed Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)
Condition: Alzheimer's Disease
Interventions: Drug: Bapineuzumab 0.5 mg/kg;   Drug: Placebo Control;   Drug: Bapineuzumab 1.0 m/kg
4 Recruiting Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: TRx0237 200 mg/day;   Drug: Placebo
5 Completed Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)
Condition: Alzheimer's Disease
Interventions: Drug: Bapineuzumab 0.5 mg/kg;   Drug: Placebo Control;   Drug: Bapineuzumab 1.0 m/kg
6 Recruiting Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Condition: Alzheimer's Disease
Interventions: Drug: Solanezumab;   Drug: Placebo
7 Unknown  Evaluation of 3APS in Patients With Mild to Moderate Alzheimer’s Disease
Condition: Alzheimer Disease
Intervention: Drug: 3APS
8 Completed Memory Impairment Study (Mild Cognitive Impairment Study)
Condition: Alzheimer Disease
Interventions: Drug: Donepezil;   Drug: Vitamin E

Indicates status has not been verified in more than two years